Sirolimus to treat SARS-CoV-2 infection: an old drug for a new disease

Sirolimus to treat SARS-CoV-2 infection: an old drug for a new disease

Bibliographic Details
Main Authors:	Antonio Romanelli, Silvia Mascolo
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences Press 2020-11-01
Series:	Journal of Research in Clinical Medicine
Subjects:	sirolimus sars-cov-2 covid-19
Online Access:	https://jrcm.tbzmed.ac.ir/PDF/jrcm-8-44.pdf

Similar Items

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
by: Jiri Patocka, et al.
Published: (2021-03-01)

Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
by: Abeba Haile Mariamenatu, et al.
Published: (2021-01-01)

Methods and resources needed in treating SARS-CoV-2 in wastewater
by: Gilbert D. Bernardino Jr, et al.
Published: (2021-02-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01)

Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key
by: Salah T. Al Awaidy
Published: (2021-03-01)

Potential Treatment Approaches to SARS-CoV-2 and Evaluation of Drug Carrier Systems in Treatment
by: Sema ARISOY, et al.
Published: (2020-12-01)

HIV and SARS-CoV-2 Co-Infection: What are the Risks?
by: Squillace N, et al.
Published: (2021-09-01)

Response to mutation and variants of the SARS-CoV-2 gene
by: M.L. Edy Parwanto
Published: (2021-05-01)

Interaction between SARS-CoV-2 and human organism
by: Gheorghe Placinta, et al.
Published: (2020-06-01)

Use of ibuprofen in the context of the SARS-CoV-2 pandemic
by: Octavia Sabin, et al.
Published: (2020-09-01)

Main Pharmacological Strategies Against SARS-CoV-2
by: Thais Gonçalves Fontes, et al.
Published: (2020-09-01)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
by: Augusta Ortolan, et al.
Published: (2021-06-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

SARS-CoV-2 and Influenza Virus Coinfection
by: Figen Kaptan
Published: (2020-12-01)

SARS-CoV-2 and Cancer: Beyond Immunosuppression
by: Diogo Mendes Pedro, et al.
Published: (2021-03-01)

Risk factors of SARS-CoV-2 infection
by: Eugene Calenici
Published: (2021-09-01)

SARS-CoV-2 infection with pneumonia and stroke
by: Muhammad Hassan, et al.
Published: (2021-06-01)

Collaborated effort against SARS‐CoV‐2 outbreak in China
by: Qiwen Yang, et al.
Published: (2020-03-01)

Management of SARS-CoV-2 infection in pregnancy
by: Cătălina Diana Stanica, et al.
Published: (2021-03-01)

Pathophysiological consequences of SARS CoV-2
by: Hadeel Hameed, et al.
Published: (2021-03-01)

Laboratory-conﬁrmed SARS-CoV-2 reinfection in the population treated at social security
by: Oscar Santiago-Espinosa, et al.
Published: (2021-01-01)

Neutralizing SARS-CoV-2
by: Eric Poeschla
Published: (2020-12-01)

Coronaviruses in pregnant women in Saudi Arabia: A systematic comparative review of MERS-CoV and SARS-CoV-2
by: Mazin Barry, et al.
Published: (2021-01-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
by: Bauso Luana Vittoria, et al.
Published: (2021-05-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

Presence of SARS-CoV-2 in a Cornea Transplant
by: Myriem Otmani Idrissi, et al.
Published: (2021-07-01)

SARS-CoV 2 in Cellular Level: Do we dominate the whole picture and how can we intervene?
by: Elif Menekşe, et al.
Published: (2021-03-01)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
by: Igor de Andrade Santos, et al.
Published: (2020-08-01)

Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
by: Shuang Dong, et al.
Published: (2020-08-01)

SARS-CoV-2 in Urine May Predict a Severe Evolution of COVID-19
by: Alessandro Perrella, et al.
Published: (2021-09-01)

SARS CoV-2 Pathogenesis and Immune Response
by: Harika Öykü DİNÇ, et al.
Published: (2020-12-01)

Cardiovascular disease in SARS‐CoV‐2 infection
by: Kei Sato, et al.
Published: (2021-01-01)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
by: Yue Zheng, et al.
Published: (2021-01-01)

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers
by: Evgenii Shumilov, et al.
Published: (2021-06-01)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
by: Alaiya A, et al.
Published: (2021-09-01)

Drug Weaponry to Fight Against SARS-CoV-2
by: Elena Cabezón, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_9ddna45uh0lchg0d3qr8ccpkmq